Literature DB >> 10340714

Non-typical lipopolysaccharide core regions of some Hafnia alvei strains: structural and serological studies.

E Romanowska1, E Katzenellenbogen, W Jachymek, T Niedziela, M Bogulska, C Lugowski.   

Abstract

The lipopolysaccharides of Hafnia alvei strains 23, 1222 and 39 were found to have non-typical core region. On the basis of sugar and methylation analyses, 1H-nuclear magnetic resonance spectra and matrix-assisted laser-desorption ionization-time of flight mass spectrometry, it was concluded that the core oligosaccharide of strains 23 and 1222 has the same structure as Escherichia coli R4 core region, and the core oligosaccharide of strain 39 has the structure of Salmonella Ra core. Using the serological methods (passive hemagglutination, enzyme-linked immunosorbent assay and immunoblotting) and the anti-conjugate sera directed against E. coli R4 and Salmonella Ra core oligosaccharides we have confirmed the structural results presented above.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10340714     DOI: 10.1111/j.1574-695X.1999.tb01266.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  3 in total

1.  Structural analysis of the lipid A isolated from Hafnia alvei 32 and PCM 1192 lipopolysaccharides.

Authors:  Jolanta Lukasiewicz; Wojciech Jachymek; Tomasz Niedziela; Lennart Kenne; Czeslaw Lugowski
Journal:  J Lipid Res       Date:  2009-08-25       Impact factor: 5.922

2.  Two Kdo-heptose regions identified in Hafnia alvei 32 lipopolysaccharide: the complete core structure and serological screening of different Hafnia O serotypes.

Authors:  Jolanta Lukasiewicz; Tomasz Niedziela; Wojciech Jachymek; Lennart Kenne; Czeslaw Lugowski
Journal:  J Bacteriol       Date:  2008-11-14       Impact factor: 3.490

3.  Interaction of Mannose-Binding Lectin With Lipopolysaccharide Outer Core Region and Its Biological Consequences.

Authors:  Aleksandra Man-Kupisinska; Anna S Swierzko; Anna Maciejewska; Monika Hoc; Antoni Rozalski; Malgorzata Siwinska; Czeslaw Lugowski; Maciej Cedzynski; Jolanta Lukasiewicz
Journal:  Front Immunol       Date:  2018-06-29       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.